Medpace Holdings, Inc. MEDP Direct Costs — Total direct costs

Other product segments

Similar metrics at other companies

IQVResearch & Development Solutions — Cost of revenues, exclusive of depreciation and amortization

$1.68B+8.0%

IQVResearch And Development Solutions — Cost Of Services Excluding Depreciation Depletion And Amortization

$971M+5.4%

NUVLDiscovery Programs — Direct Expenses Related To Program

$2.8M+31.4%

NUVLNeladalkib — Direct Expenses Related To Program

$26.32M-6.0%

IQVContract Sales And Medical Solutions — Cost Of Services Excluding Depreciation Depletion And Amortization

$172M+0.6%

HCAPatient Care Costs

$16.25B+5.0%

Questions, answered.

What is Medpace Holdings, Inc.'s direct costs — total direct costs?

Medpace Holdings, Inc. (MEDP) reported direct costs — total direct costs of $198.27M in Q1 2026.

How has Medpace Holdings, Inc.'s direct costs — total direct costs changed year-over-year?

Medpace Holdings, Inc.'s direct costs — total direct costs increased by 11.5% year-over-year, from $177.82M to $198.27M.

What is the long-term trend for Medpace Holdings, Inc.'s direct costs — total direct costs?

Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s direct costs — total direct costs has grown at a 13.5% compound annual growth rate (CAGR), from $441.09M to $732.13M.

What does direct costs — total direct costs mean?

The total cost of providing services directly to clients in clinical research projects.

How do you interpret direct costs — total direct costs?

An increase relative to revenue may indicate margin compression or operational inefficiencies, while a decrease relative to revenue suggests improved project execution or economies of scale.

How does direct costs — total direct costs compare across companies?

Comparable to Cost of Services or Cost of Revenue in other contract research organizations (CROs).